A Note Before You Begin Weight loss injections have become one of the most searched health topics of the past three years, and for good reason. GLP-1 receptor agonists such as semaglutide and tirzepatide have delivered clinical results that were once considered impossible without surgery: 15 to 22 percent total body weight loss in randomised controlled trials, with meaningful improvements in blood sugar, blood pressure, and cardiovascular risk markers. The surge in demand has created a...

Pregnancy changes the body in profound ways. Among the most persistent, and least discussed, is what happens to the skin of the abdomen after delivery. For many women, particularly after significant weight gain during pregnancy or multiple pregnancies, the stomach skin does not simply spring back once the baby is born and the weight comes off. What remains is a softness, a looseness, a crepe-like quality to the skin that no amount of core exercise or clean eating seems to fully address. It is...

Across obesity medicine clinics worldwide, a pattern keeps repeating itself. A patient starts tirzepatide or semaglutide, loses weight in the first few months, and then either plateaus earlier than expected, loses disproportionate amounts of muscle alongside fat, or regains weight rapidly once the medication is paused. They come back frustrated, wondering why the medication "worked for others but not for them." In almost every case, the medication is not the problem. The programme surrounding...